BioPharma Dive - Latest News

Second Duchenne patient dies after receiving Sarepta gene therapy

Another person treated with Elevidys suffered acute liver failure, leading Sarepta to discontinue treatment in certain patients while it evaluates new safety precautions. 

Jun 16, 2025 - 15:00
 0
Second Duchenne patient dies after receiving Sarepta gene therapy

Another person treated with Elevidys suffered acute liver failure, leading Sarepta to discontinue treatment in certain patients while it evaluates new safety precautions. 

Read More

Tags:

Previous Article

FDA to miss approval deadline for Kalvista drug due to ‘resource constraints’

Next Article

STAT+: Lilly’s amylin candidate shows early promise 

Related Posts

Genetics is a missing link in kidney disease drug development

Genetics is a missing link in kidney disease drug devel...

Jun 2, 2025  0

FDA panel backs Darzalex for early stage multiple myeloma

FDA panel backs Darzalex for early stage multiple myeloma

May 21, 2025  0

SpliceBio lands $135M for a new kind of eye gene therapy

SpliceBio lands $135M for a new kind of eye gene therapy

Jun 11, 2025  0